Follow
Monique Andersson
Monique Andersson
Oxford University Hospitals NHS Foundation Trust, University of Oxford, University of Stellenbosch
Verified email at sun.ac.za
Title
Cited by
Cited by
Year
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
20562017
Development of the quinolones
MI Andersson, AP MacGowan
Journal of Antimicrobial Chemotherapy 51 (suppl_1), 1-11, 2003
7482003
Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018
DW Eyre, ND Sanderson, E Lord, N Regisford-Reimmer, K Chau, ...
Eurosurveillance 23 (27), 1800323, 2018
3262018
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ...
The Lancet Infectious Diseases 20 (12), 1390-1400, 2020
3162020
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ...
The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022
2912022
SARS-CoV-2 within-host diversity and transmission
KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ...
Science 372 (6539), eabg0821, 2021
2872021
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
LM Yu, M Bafadhel, J Dorward, G Hayward, BR Saville, O Gbinigie, ...
The Lancet 398 (10303), 843-855, 2021
2812021
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study
DW Eyre, SF Lumley, D O'Donnell, M Campbell, E Sims, E Lawson, ...
elife 9, e60675, 2020
2672020
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform …
CC Butler, FDR Hobbs, OA Gbinigie, NM Rahman, G Hayward, ...
The Lancet 401 (10373), 281-293, 2023
2562023
The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm–volume 2
A Hatzakis, V Chulanov, AC Gadano, C Bergin, Z Ben‐Ari, J Mossong, ...
Journal of viral hepatitis 22, 26-45, 2015
246*2015
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
ER Adams, M Ainsworth, R Anand, MI Andersson, K Auckland, JK Baillie, ...
Wellcome Open Research 5, 2020
2212020
SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus
MI Andersson, CV Arancibia-Carcamo, K Auckland, JK Baillie, E Barnes, ...
Wellcome open research 5, 2020
1702020
The duration, dynamics, and determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody responses in individual healthcare workers
SF Lumley, J Wei, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ...
Clinical Infectious Diseases 73 (3), e699-e709, 2021
1582021
Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic …
KD Vihta, N Stoesser, MJ Llewelyn, TP Quan, T Davies, NJ Fawcett, ...
The Lancet Infectious Diseases 18 (10), 1138-1149, 2018
1482018
Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples
K Lewandowski, Y Xu, ST Pullan, SF Lumley, D Foster, N Sanderson, ...
Journal of clinical microbiology 58 (1), 10.1128/jcm. 00963-19, 2019
1432019
Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 2
V Saraswat, S Norris, RJ De Knegt, JF Sanchez Avila, M Sonderup, ...
Journal of viral hepatitis 22, 6-25, 2015
1422015
Hepatitis B virus infection as a neglected tropical disease
GA O’Hara, AL McNaughton, T Maponga, P Jooste, P Ocama, R Chilengi, ...
PLoS neglected tropical diseases 11 (10), e0005842, 2017
1052017
Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays
E Adams, M Ainsworth, R Anand, MI Andersson, K Auckland, JK Baillie, ...
MedRxiv, 2020
1012020
Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018
AV Jennison, D Whiley, MM Lahra, RM Graham, MJ Cole, G Hughes, ...
Eurosurveillance 24 (8), 1900118, 2019
932019
Strategies to manage hepatitis C virus (HCV) infection disease burden–volume 2
E Gane, D Kershenobich, C Seguin‐Devaux, P Kristian, I Aho, O Dalgard, ...
Journal of viral hepatitis 22, 46-73, 2015
912015
The system can't perform the operation now. Try again later.
Articles 1–20